常茂生物(股票代码:00954)于2026年9月1日披露了截至2026年8月31日的证券变动月报表。根据公告,8月期间公司各类已发行股份数量和注册股本均无变动。
公告显示,该公司法定注册资本总额为人民币52,970,000元。其中,已发行H股183,700,000股,面值为每股人民币0.1元,对应注册股本18,370,000元;内资股2,500,000股,面值为每股人民币0.1元,对应注册股本250,000元;外资股343,500,000股,面值为每股人民币0.1元,对应注册股本34,350,000元。以上数据均较7月底保持不变。
同时,公告明确显示当月公司未进行任何新股发行、回购、注销或库藏股变动,亦无股份期权或股权激励计划调整事宜。公司声明已遵守香港联合交易所《上市规则》及其他相关法律法规的规定,并由公司秘书温珮玲签署确认。
截至2026年8月末,公司股本结构维持稳定,总股本保持在183,700,000股H股、2,500,000股内资股及343,500,000股外资股的水平。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.